Madison Street Capital

Madison Street Capital, an international investment banking firm, has acted as a co-advisor in the sale of Therachem Research Medilab ("TRM") and Solaris Pharmachem by PI Health Sciences, ("PIHS"), a wholly owned subsidiary of PI Industries ("PI"). Along with Madison Street Capital, That's Nice LLC was a co-advisor in the $75 million deal. Charles Botchway, CEO of Madison Street Capital, announced that Barry Petersen, Sr. Managing Director, led the Madison Street Capital team.

Therachem Research Medilab is a chemistry-driven global service provider for pharmaceutical and biopharmaceutical companies. Solaris Pharmachem is a leading specialty pharmaceutical company committed to the identifying, developing, and marketing of high-quality, complex, generic and specialty pharmaceutical products.

Barry Petersen, Sr. Managing Director at Madison Street Capital, stated: "We are pleased to have assisted Therachem Research Medilab in achieving a successful result from this M&A process. The combination of PI Health Sciences and TRM is highly synergistic and will be beneficial to the entire Pharma value chain. We wish Dr. Chand continued success moving forward."